0001708138-17-000009.txt : 20170621 0001708138-17-000009.hdr.sgml : 20170621 20170621161236 ACCESSION NUMBER: 0001708138-17-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 17923028 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-06-20 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2017-06-20 4 M 0 1000 273.67 A 14000 D Common Stock 2017-06-20 4 S 0 1000 500.01 D 13000 D Non-Qualified Stock Option (right to buy) 273.67 2017-06-20 4 M 0 1000 0.0 D 2024-01-02 Common Stock 1000 6500 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 1,000 shares of Company stock on June 20, 2017 at prices ranging from $500.00 to $500.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 20, 2017 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Joseph L. Goldstein 2017-06-20